Skip to main content
Erschienen in: The European Journal of Health Economics 5/2018

26.07.2017 | Original Paper

Smoking, health-related quality of life and economic evaluation

verfasst von: Ángel López-Nicolás, Marta Trapero-Bertran, Celia Muñoz

Erschienen in: The European Journal of Health Economics | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Background and aims

The economic evaluation of tobacco control policies requires the adoption of assumptions about the impact of changes in smoking status on health-related quality of life (HRQoL). Estimates for such impacts are necessary for different populations. This paper aims to test whether smoking status has an independent effect on HRQoL over and above the effect derived from the increased likelihood of suffering a tobacco related disease, and to calculate utility values for the Spanish population.

Methods

Using data from the Spanish Encuesta Nacional de Salud of 2011–12, we estimate statistical models for HRQoL as measured by the EQ-5D-5L instrument as a function of smoking status. We include a comprehensive set of controls for biological, clinical, lifestyle and socioeconomic characteristics.

Results

Smoking status has an independent, statistically significant effect on HRQoL. However, the size of the effect is small. The typical smoking related diseases, such as lung cancer, are associated with a reduction in HRQoL about 5 times larger than the difference between current smokers and never smokers.

Conclusion

Attributing substantive HRQoL gains to quitting smoking as well as accounting for the concomitant HRQoL gain derived from a smaller likelihood of contracting tobacco related diseases might lead to an overestimation of the benefits of tobacco control policies. Nonetheless, the relatively large drops in HRQoL associated with being diagnosed with diseases that might be causally linked to tobacco suggest that such diseases should not be omitted from the economic evaluations of tobacco control policies.
Fußnoten
1
The Short Form-36 (SF-36) questionnaire is an established and also widely used health-related quality of life measure (HRQoL) [19]. It comprises eight health domains including ‘physical functioning’ [19].
 
2
The estimation of the second part of the model uses a smaller number of observations than the estimation for the first part. As reflected in Table 1, the sample sizes are 2770 for men and 5117 for women. However, these samples contain variation in smoking status: among males there are 952 never smokers, 796 current smokers and 1022 former smokers and among women the corresponding figures are 3729, 845 and 543.
 
Literatur
3.
Zurück zum Zitat US Department of Health and Human Services. The health consequences of smoking—50 years of progress: a report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Atlanta, GA (2014) US Department of Health and Human Services. The health consequences of smoking—50 years of progress: a report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Atlanta, GA (2014)
6.
Zurück zum Zitat Weinstein, M.C., Torrance, G., McGuire, A.: QALYs: the basics. Value Health 12(1), S5–S9 (2009)CrossRefPubMed Weinstein, M.C., Torrance, G., McGuire, A.: QALYs: the basics. Value Health 12(1), S5–S9 (2009)CrossRefPubMed
8.
Zurück zum Zitat Ramos-Goni, J.M., Pinto-Prades, J.L., Oppe, M., Cabases, J.M., Serrano-Aguilar, P., Rivero-Arias, O.: Valuation and modeling of EQ-5D-5L health states using a hybrid approach. Med. Care (2014). doi:10.1097/MLR.0000000000000283 Ramos-Goni, J.M., Pinto-Prades, J.L., Oppe, M., Cabases, J.M., Serrano-Aguilar, P., Rivero-Arias, O.: Valuation and modeling of EQ-5D-5L health states using a hybrid approach. Med. Care (2014). doi:10.​1097/​MLR.​0000000000000283​
9.
11.
Zurück zum Zitat Over, E.A., Feenstra, T.L., Hoogenveen, R.T., Droomers, M., Uiters, E., van Gelder, B.M.: Tobacco control policies specified according to socioeconomic status: health disparities and cost-effectiveness. Nicotine Tob. Res. 16, 725–732 (2014). doi:10.1093/ntr/ntt218 CrossRefPubMed Over, E.A., Feenstra, T.L., Hoogenveen, R.T., Droomers, M., Uiters, E., van Gelder, B.M.: Tobacco control policies specified according to socioeconomic status: health disparities and cost-effectiveness. Nicotine Tob. Res. 16, 725–732 (2014). doi:10.​1093/​ntr/​ntt218 CrossRefPubMed
12.
Zurück zum Zitat Howard, P., Knight, C., Boler, A., Baker, C.: Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO simulation model: application to a population of US adult smokers. Pharmacoeconomics 26, 497–511 (2008)CrossRefPubMed Howard, P., Knight, C., Boler, A., Baker, C.: Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO simulation model: application to a population of US adult smokers. Pharmacoeconomics 26, 497–511 (2008)CrossRefPubMed
13.
Zurück zum Zitat Stanczyk, N.E., Smit, E.S., Schulz, D.N., de Vries, H., Bolman, C., Muris, J.W., et al.: An economic evaluation of a video- and text-based computer-tailored intervention for smoking cessation: a cost-effectiveness and cost-utility analysis of a randomized controlled trial. PLoS One 9, e110117 (2014). doi:10.1371/journal.pone.011011 CrossRefPubMedPubMedCentral Stanczyk, N.E., Smit, E.S., Schulz, D.N., de Vries, H., Bolman, C., Muris, J.W., et al.: An economic evaluation of a video- and text-based computer-tailored intervention for smoking cessation: a cost-effectiveness and cost-utility analysis of a randomized controlled trial. PLoS One 9, e110117 (2014). doi:10.​1371/​journal.​pone.​011011 CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat de Fernandez, B.O.J., Sanchez-Maestre, C., Brosa Riestra, M., Arroyo, O., Sanz de Burgoa, V., Wilson, K.: Cost effectiveness analysis of varenicline (Champix) for the treatment of smoking in Spain. Ann. Med. Intern. 25, 342–348 (2008). (in Spanish) de Fernandez, B.O.J., Sanchez-Maestre, C., Brosa Riestra, M., Arroyo, O., Sanz de Burgoa, V., Wilson, K.: Cost effectiveness analysis of varenicline (Champix) for the treatment of smoking in Spain. Ann. Med. Intern. 25, 342–348 (2008). (in Spanish)
15.
Zurück zum Zitat Becona, E., Vazquez, M.I., Miguez Mdel, C., Fernandez del Rio, E., Lopez-Duran, A., Martinez, U., et al.: Smoking habit profile and health-related quality of life. Psicothema 25, 421–426 (2013). doi:10.7334/psicothema2013.73 PubMed Becona, E., Vazquez, M.I., Miguez Mdel, C., Fernandez del Rio, E., Lopez-Duran, A., Martinez, U., et al.: Smoking habit profile and health-related quality of life. Psicothema 25, 421–426 (2013). doi:10.​7334/​psicothema2013.​73 PubMed
16.
Zurück zum Zitat Cayuela, A., Rodriguez-Dominguez, S., Otero, R.: Deteriorated health-related quality of life in healthy male smokers. Arch. Bronconeumol. 43, 59–63 (2007). (in Spanish) CrossRefPubMed Cayuela, A., Rodriguez-Dominguez, S., Otero, R.: Deteriorated health-related quality of life in healthy male smokers. Arch. Bronconeumol. 43, 59–63 (2007). (in Spanish) CrossRefPubMed
17.
Zurück zum Zitat Guiterrez-Bedmar, M., Segui-Gomez, M., Gomez-Gracia, E., Bes-Rastrollo, M., Martinez-Gonzalez, M.A.: Smoking status, changes in smoking status and health-related quality of life: findings from the SUN (“Seguimiento Universidad de Navarra”) cohort. Int. J. Environ. Res. Public Health 6, 310–320 (2009). doi:10.3390/ijerph6010310 CrossRefPubMedPubMedCentral Guiterrez-Bedmar, M., Segui-Gomez, M., Gomez-Gracia, E., Bes-Rastrollo, M., Martinez-Gonzalez, M.A.: Smoking status, changes in smoking status and health-related quality of life: findings from the SUN (“Seguimiento Universidad de Navarra”) cohort. Int. J. Environ. Res. Public Health 6, 310–320 (2009). doi:10.​3390/​ijerph6010310 CrossRefPubMedPubMedCentral
18.
19.
Zurück zum Zitat Ware Jr., J.E., Gandek, B.: Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J. Clin. Epidemiol. 51, 903–912 (1998)CrossRefPubMed Ware Jr., J.E., Gandek, B.: Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J. Clin. Epidemiol. 51, 903–912 (1998)CrossRefPubMed
22.
Zurück zum Zitat Brooks RG. 28 Years of the EuroQol Group: an overview. EuroQol Working Paper Series, 2015. EuroQol Group. file:///C:/Users/Marta%20Trapero/Downloads/EuroQol_Working_Paper_Series_Manuscript_15003_-_Richard_Brooks_02.pdf (2015). Accessed on May 2017 Brooks RG. 28 Years of the EuroQol Group: an overview. EuroQol Working Paper Series, 2015. EuroQol Group. file:///C:/Users/Marta%20Trapero/Downloads/EuroQol_Working_Paper_Series_Manuscript_15003_-_Richard_Brooks_02.pdf (2015). Accessed on May 2017
Metadaten
Titel
Smoking, health-related quality of life and economic evaluation
verfasst von
Ángel López-Nicolás
Marta Trapero-Bertran
Celia Muñoz
Publikationsdatum
26.07.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
The European Journal of Health Economics / Ausgabe 5/2018
Print ISSN: 1618-7598
Elektronische ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-017-0919-1

Weitere Artikel der Ausgabe 5/2018

The European Journal of Health Economics 5/2018 Zur Ausgabe